Effect of intravesical glycosaminoglycan substitution therapy on bladder pain syndrome/interstitial cystitis, bladder capacity and potassium sensitivity

Scandinavian Journal of Urology and Nephrology

Volumn 42, Issue 4, 2008, Pages 369-372

  Daha, Lukas K ^a,c   Riedl, Claus R ^b   Lazar, Dara ^a   Simak, Reiner ^a   Pflüger, Heinz ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b Thermenklinikum Baden ^*  (Austria)

^c GENERAL HOSPITAL LINZ   (Austria)

Author keywords

Bladder; Hyaluronic acid; Interstitial cystitis; Pain; Pentosanpolysulfate; Potassium test

Indexed keywords

GLYCOSAMINOGLYCAN; HYALURONIC ACID; PENTOSAN POLYSULFATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE;

ADULT; ARTICLE; BLADDER CAPACITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTALGIA; CYSTOMETRY; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG INSTILLATION; DRUG RESPONSE; FEMALE; HUMAN; INTERSTITIAL CYSTITIS; MODIFIED COMPARATIVE POTASSIUM TEST; PRIORITY JOURNAL; SUBSTITUTION THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; CYSTITIS, INTERSTITIAL; FEMALE; FOLLOW-UP STUDIES; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; MIDDLE AGED; PENTOSAN SULFURIC POLYESTER; POTASSIUM CHLORIDE; PROSPECTIVE STUDIES; URINARY BLADDER;

EID: 51649101288     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590701871518     Document Type: Article

References (23)

1. Ratliff TL, Klutke CG, McDougall EM. The etiology of interstitial cystitis. Urol Clin N Am 1994;21:21-30.
2. Hohlbrugger G. Leaky urothelium and/or vesical ischemia enable urinary potassium to cause idiopathic urgency/frequency syndrome and urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1996;7:242-55.
3. Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 1991;145:732-5.
4. Moss NG, Harrington WW, Tucker MS. Pressure, volume, and chemosensitivity in afferent innervation of urinary bladder in rats. Am J Physiol 1997;272:R695-703.
5. Parsons CL. Potassium sensitivity test. Techn Urol 1996;2:171-3.
6. Philip J, Irwin PP. Can the potassium test be explained by an effect on detrusor activity? A prospective double-blinded study. J Urol 2004;171(Suppl A):93.
7. Daha LK, Riedl CR, Hohlbrugger G, Knoll M, Engelhardt PF, Pflüger H. Comparative assessment of maximal bladder capacity, 0.9% NaCl vs. 0.2 M KCl, for the diagnosis of interstitial cystitis: a prospective controlled study. J Urol 2003;170:807-9.
8. Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol 1994;73:504-7.
9. Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ. A placebo controlled study of intravesical pentosanpolysulfate for the treatment of interstitial cystitis. Br J Urol 1997;79:168-71.
10. Steinhoff G, Ittah B, Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol 2002;9:1454-8.
11. Riedl CR, Daha LK, Pflüger H, Hohlbrugger G. Intravesical hyaluronic acid for the treatment of interstitial cystitis: an update. Eur Urol 2004;Suppl 3:235.
12. Morales A, Emerson L, Nickel JC, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 1996;156:45-8.
13. Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, et al. Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 1997;59:26-9.
14. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988;140:203.
15. Hurst RE, Zebrowski R. Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J Urol 1994;152:1641-4.
16. Hurst RE. Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 1994;12:3-10.
17. Buckley MS, Washington S, Laurent C, Erickson DE, Bhavanandan VP. Characterization and immunohistochemical localization of the glycoconjugates of the rabbit bladder mucosa. Arch Biochem Biophys 1996;330:163-73.
18. Leppilahti M, Hellström P, Tammela TL. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 2002;60:46-51.
19. Turley EA, Austen L, Moore D, Hoare K. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion. Exp Cell Res 1993;207:277-82.
20. Parsons CL, Forrest J, Nickel JC, Evans R, Lloyd LK, Barkin J, et al. Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 2002;59:329-33.
21. Kallestrup EB, Steinunn S, Jørgensen S, Nordling J, Hald T. Treatment of interstitial cystitis with Cystistat®: a hyaluronic acid product. Scand J Urol Nephrol 2005;39:143-7.
22. Gupta SK. Re: Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pfluger H. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol 2005;47:393-7. Eur Urol 2005;48:534.
23. Teichman JMH, Nielsen-Omeis BJ. Potassium leak test predicts outcome in interstitial cystitis. J Urol 1999;161:1791-6.